Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_assertion type Assertion NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_head.
- NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_assertion description "[3;q32.3) may provide myeloma cells with a growth advantage via an autocrine mechanism between FGFR3 and FGF-4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_provenance.
- NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_assertion evidence source_evidence_literature NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_provenance.
- NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_assertion SIO_000772 10568829 NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_provenance.
- NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_assertion wasDerivedFrom befree-2016 NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_provenance.
- NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_assertion wasGeneratedBy ECO_0000203 NP268068.RAb31PxFkrtl_HBmAqEVev4smrNqd-7_oD6AcVNHnvdnE130_provenance.